GSK plc (GSK)
NYSE: GSK · IEX Real-Time Price · USD
39.27
-0.33 (-0.83%)
At close: Apr 18, 2024, 4:00 PM
39.24
-0.03 (-0.08%)
After-hours: Apr 18, 2024, 7:18 PM EDT
GSK Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 2,936 | 3,723 | 4,274 | 6,292 | 4,707 | 3,874 | 3,833 | 4,897 | 5,830 | 4,338 | Upgrade
|
| Short-Term Investments | 2,246 | 4,154 | 61 | 78 | 79 | 84 | 78 | 89 | 75 | 69 | Upgrade
|
| Cash & Cash Equivalents | 5,182 | 7,877 | 4,335 | 6,370 | 4,786 | 3,958 | 3,911 | 4,986 | 5,905 | 4,407 | Upgrade
|
| Cash Growth | -34.21% | 81.71% | -31.95% | 33.10% | 20.92% | 1.20% | -21.56% | -15.56% | 33.99% | -21.30% | Upgrade
|
| Receivables | 7,385 | 7,053 | 7,860 | 6,952 | 7,202 | 6,423 | 6,000 | 6,026 | 5,615 | 4,600 | Upgrade
|
| Inventory | 5,498 | 5,146 | 5,783 | 5,996 | 5,947 | 5,476 | 5,557 | 5,102 | 4,716 | 4,231 | Upgrade
|
| Other Current Assets | 579 | 693 | 696 | 929 | 1,556 | 1,070 | 439 | 597 | 351 | 1,440 | Upgrade
|
| Total Current Assets | 18,644 | 20,769 | 18,674 | 20,247 | 19,491 | 16,927 | 15,907 | 16,711 | 16,587 | 14,678 | Upgrade
|
| Property, Plant & Equipment | 9,957 | 9,620 | 10,672 | 11,006 | 11,314 | 11,058 | 10,860 | 10,808 | 9,668 | 9,052 | Upgrade
|
| Long-Term Investments | 1,192 | 1,541 | 2,214 | 3,424 | 2,151 | 1,558 | 1,101 | 1,248 | 1,462 | 1,454 | Upgrade
|
| Goodwill and Intangibles | 21,579 | 21,364 | 40,631 | 40,421 | 41,517 | 22,991 | 23,296 | 24,741 | 21,834 | 12,044 | Upgrade
|
| Other Long-Term Assets | 7,633 | 6,852 | 6,912 | 5,333 | 5,219 | 5,532 | 5,217 | 5,573 | 3,895 | 3,423 | Upgrade
|
| Total Long-Term Assets | 40,361 | 39,377 | 60,429 | 60,184 | 60,201 | 41,139 | 40,474 | 42,370 | 36,859 | 25,973 | Upgrade
|
| Total Assets | 59,005 | 60,146 | 79,103 | 80,431 | 79,692 | 58,066 | 56,381 | 59,081 | 53,446 | 40,651 | Upgrade
|
| Accounts Payable | 15,844 | 16,263 | 17,554 | 15,840 | 14,939 | 14,037 | 20,970 | 11,964 | 8,885 | 7,958 | Upgrade
|
| Current Debt | 2,813 | 3,952 | 3,601 | 3,725 | 6,918 | 5,793 | 2,825 | 4,129 | 1,308 | 2,943 | Upgrade
|
| Other Current Liabilities | 2,411 | 2,595 | 2,515 | 2,583 | 2,193 | 2,661 | 2,774 | 2,908 | 3,224 | 2,394 | Upgrade
|
| Total Current Liabilities | 21,068 | 22,810 | 23,670 | 22,148 | 24,050 | 22,491 | 26,569 | 19,001 | 13,417 | 13,295 | Upgrade
|
| Long-Term Debt | 15,205 | 17,035 | 20,572 | 23,425 | 23,590 | 20,271 | 14,264 | 14,661 | 15,324 | 15,841 | Upgrade
|
| Other Long-Term Liabilities | 9,937 | 10,205 | 13,519 | 14,050 | 13,695 | 11,632 | 12,059 | 20,456 | 15,827 | 6,579 | Upgrade
|
| Total Long-Term Liabilities | 25,142 | 27,240 | 34,091 | 37,475 | 37,285 | 31,903 | 26,323 | 35,117 | 31,151 | 22,420 | Upgrade
|
| Total Liabilities | 46,210 | 50,050 | 57,761 | 59,623 | 61,335 | 54,394 | 52,892 | 54,118 | 44,568 | 35,715 | Upgrade
|
| Total Debt | 18,018 | 20,987 | 24,173 | 27,150 | 30,508 | 26,064 | 17,089 | 18,790 | 16,632 | 18,784 | Upgrade
|
| Debt Growth | -14.15% | -13.18% | -10.97% | -11.01% | 17.05% | 52.52% | -9.05% | 12.97% | -11.46% | 2.95% | Upgrade
|
| Retained Earnings | 7,239 | 4,363 | 7,944 | 6,755 | 4,530 | -2,716 | -6,477 | -5,392 | -1,397 | -2,074 | Upgrade
|
| Shareholders' Equity | 13,347 | 10,598 | 15,055 | 14,587 | 11,405 | 3,781 | -68 | 1,124 | 5,114 | 4,263 | Upgrade
|
| Net Cash / Debt | -12,836 | -13,110 | -19,838 | -20,780 | -25,722 | -22,106 | -13,178 | -13,804 | -10,727 | -14,377 | Upgrade
|
| Working Capital | -2,424 | -2,041 | -4,996 | -1,901 | -4,559 | -5,564 | -10,662 | -2,290 | 3,170 | 1,383 | Upgrade
|
| Book Value Per Share | 6.58 | 5.26 | 7.51 | 7.31 | 5.74 | 1.91 | -0.04 | 0.58 | 2.63 | 2.19 | Upgrade
|
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).